Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D043582 |
5-alpha-Dihydroprogesterone |
5-alpha-Dihydroprogesterone results in increased expression of SOX10 mRNA | increases expression | 17478888
|
D043582 |
5-alpha-Dihydroprogesterone |
5-alpha-Dihydroprogesterone results in increased expression of SOX10 protein | increases expression | 17478888
|
D001205 |
Ascorbic Acid |
Ascorbic Acid results in increased expression of SOX10 mRNA | increases expression | 15305145
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SOX10 mRNA | affects cotreatment|decreases expression | 20360939
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SOX10 mRNA | affects cotreatment|decreases expression | 20360939
|
D005047 |
Etoposide |
SOX10 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D011374 |
Progesterone |
Progesterone results in increased expression of SOX10 mRNA | increases expression | 17478888
|
D011374 |
Progesterone |
Progesterone results in increased expression of SOX10 protein | increases expression | 17478888
|
C406527 |
R 115866 |
R 115866 results in decreased expression of SOX10 protein | decreases expression | 17047027
|
D014212 |
Tretinoin |
[Tretinoin co-treated with EGF protein co-treated with NOG protein] results in increased expression of SOX10 mRNA | affects cotreatment|increases expression | 17196394
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of SOX10 mRNA | increases expression | 17038669
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.98 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.24 | 17162532 16434500 18056438 17620307 19052882 19061943 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.81 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.40 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.68 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.85 | 16197459 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.54 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.71 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.56 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
2.43 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.43 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.43 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.43 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.43 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.93 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.13 | 16540662 17138121 10672840 20084675 16698587 16807293 16878318 19171122 19383236 18665156 19701751 18971187 18210153 17761372 18788625 19822196 18056438 19394651 16830150 16288022 16569478 20512989 20727157 3581430 19919837 20007298 19208518 17428255 3084413 17173139 16502159 10737359 19107877 19335982 19539802 21159647 18506893 20524982 16935385 17978847 20214788 11831363 19418558 16779866 16681979 18785209 18691550 19519916 18978308 20935162 16328049 17055752 20432363 19052882 18494052 18393292 20101231 17162532 20514400 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.13 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.34 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.22 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.01 | 17174075 2727394 21159647 7505956 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.93 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.90 | 19052882 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.75 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.01 | 17035595 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.85 | 17323712 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9664655 8800419 16925845 9125849 9142499 17551590 14991402 10589399 9211117 9224671 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
4.91 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.91 | 20387270 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.80 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
2.11 | 19107877 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.85 | 9068938 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.84 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.06 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.25 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.99 | 16134523 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.49 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.75 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.43 | 21071580 20387270 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.82 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.15 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.34 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
7.44 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
7.44 | 14991402 9664655 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.54 | 16490937 16863852 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.90 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
4.08 | 16200630 15147373 16135485 18180244 17606976 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.40 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.88 | 16778211 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.71 | 15869954 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.54 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.54 | 15869954 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.07 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.81 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.14 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
3.67 | 15369732 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.87 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.94 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
8.42 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.42 | 16140955 16935935 16823087 16788101 17712046 17368321 17339181 12679006 17361223 17217047 17294898 17506722 19642359 16766008 9834237 15748426 19035177 16331271 17107899 19225113 19075265 17301526 19029980 17649720 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.47 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.94 | 18407596 18665156 20032147 19638242 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.15 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.31 | 20501860 20434301 19255062 19551842 19499222 19812893 15885732 19256749 18644402 12771043 15175105 20452335 2862719 16942905 19996281 9163691 19254457 19850985 20583210 12112319 18648771 2422723 18977376 19427195 21167192 20137499 20118626 20492335 18978307 21047994 21071580 19833225 19690152 10737359 19642983 20405173 19294768 19090486 21278145 19073162 18754104 19426721 20101389 19638242 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
6.76 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.76 | 19539802 18164116 18308698 18253720 16267830 18544905 19519916 17942915 16842330 3124819 18282651 18079962 21159647 19126423 19004024 17854601 17174075 18775883 9362446 2563599 19009564 18093689 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
4.10 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
2.84 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.84 | 20512841 20970405 21163286 6695378 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
4.09 | 12854902 12556972 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
3.01 | 11408345 17203775 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.86 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.73 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.20 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.65 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.51 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.06 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.20 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.54 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.49 | 20387270 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
3.19 | 17217161 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.13 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.13 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.10 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
9.15 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
9.15 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
9.15 | 15976015 |
OMIM:609136 |
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE |
marker/mechanism |
|
| |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.77 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.98 | 17172428 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.86 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.13 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
5.71 | 14606601 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.36 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.36 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.92 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
4.99 | 14601052 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.26 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.70 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.62 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.47 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.47 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
4.13 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
4.48 | 16517955 16403987 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.78 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.78 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.02 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.36 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.90 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.99 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.34 | 16761959 |
OMIM:611584 |
WAARDENBURG SYNDROME, TYPE 2E |
marker/mechanism |
|
| |
OMIM:277580 |
WAARDENBURG SYNDROME, TYPE 4A |
marker/mechanism |
|
| |
OMIM:613266 |
WAARDENBURG SYNDROME, TYPE 4C |
marker/mechanism |
|
| |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.18 | 16287080 |
MESH:C536771 |
Yemenite deaf-blind hypopigmentation syndrome |
marker/mechanism |
|
| |